235
Participants
Start Date
August 31, 2003
Primary Completion Date
June 30, 2008
Study Completion Date
June 30, 2008
Sildenafil citrate
oral; 20mg, 40mg and 80 mg; 3 times a day(TID)
Sildenafil citrate
oral; 10mg, 20mg and 40mg; 3 times a day(TID)
Placebo
oral; 3 times a day(TID)
Sildenafil citrate
oral; 10 mg; 3 times a day(TID)
Pfizer Investigational Site, Medellín
Pfizer Investigational Site, Bogota
Pfizer Investigational Site, Taipei
Pfizer Investigational Site, Budapest
Pfizer Investigational Site, Budapest
Pfizer Investigational Site, Szeged
Pfizer Investigational Site, Deszk
Pfizer Investigational Site, Szeged
Pfizer Investigational Site, New York
Pfizer Investigational Site, George Town
Pfizer Investigational Site, George Town
Pfizer Investigational Site, Taipei
Pfizer Investigational Site, Del. Tlalpan
Pfizer Investigational Site, Tlalpan
Pfizer Investigational Site, Charleston
Pfizer Investigational Site, Bologna
Pfizer Investigational Site, Columbus
Pfizer Investigational Site, Ann Arbor
Pfizer Investigational Site, St Louis
Pfizer Investigational Site, Aurora
Pfizer Investigational Site, Kaohsiung City
Pfizer Investigational Site, Palo Alto
Pfizer Investigational Site, Stanford
Pfizer Investigational Site, Seattle
Pfizer Investigational Site, Moscow
Pfizer Investigational Site, Moscow
Pfizer Investigational Site, Boston
Pfizer Investigational Site, São Paulo
Pfizer Investigational Site, Edmonton
Pfizer Investigational Site, Santiago
Pfizer Investigational Site, Guatemala City
Pfizer Investigational Site, Tokyo
Pfizer Investigational Site, Hyderabad
Pfizer Investigational Site, Kerala
Pfizer Investigational Site, Lima
Pfizer Investigational Site, Krakow
Pfizer Investigational Site, Krakow
Pfizer Investigational Site, Warsaw
Pfizer Investigational Site, Warsaw
Pfizer Investigational Site, Zabrze
Pfizer Investigational Site, Lund
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY